NO20010982D0 - FremgangsmÕte for Õ administrere insulinotropiske peptider - Google Patents
FremgangsmÕte for Õ administrere insulinotropiske peptiderInfo
- Publication number
- NO20010982D0 NO20010982D0 NO20010982A NO20010982A NO20010982D0 NO 20010982 D0 NO20010982 D0 NO 20010982D0 NO 20010982 A NO20010982 A NO 20010982A NO 20010982 A NO20010982 A NO 20010982A NO 20010982 D0 NO20010982 D0 NO 20010982D0
- Authority
- NO
- Norway
- Prior art keywords
- administering
- insulinotropic peptides
- insulinotropic
- peptides
- administering insulinotropic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9827398P | 1998-08-28 | 1998-08-28 | |
US10001298P | 1998-09-11 | 1998-09-11 | |
PCT/US1999/019348 WO2000012116A1 (en) | 1998-08-28 | 1999-08-24 | Method for administering insulinotropic peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010982D0 true NO20010982D0 (no) | 2001-02-27 |
NO20010982L NO20010982L (no) | 2001-04-27 |
Family
ID=26794577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010982A NO20010982L (no) | 1998-08-28 | 2001-02-27 | Fremgangsmåte for å administrere insulinotropiske peptider |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0997151B1 (no) |
JP (1) | JP2002523466A (no) |
KR (1) | KR20010073033A (no) |
CN (1) | CN1314818A (no) |
AR (1) | AR022368A1 (no) |
AT (1) | ATE347902T1 (no) |
AU (1) | AU764371B2 (no) |
BR (1) | BR9913284A (no) |
CA (1) | CA2341454A1 (no) |
CO (1) | CO5090908A1 (no) |
CZ (1) | CZ2001690A3 (no) |
DE (1) | DE69934380D1 (no) |
EA (1) | EA200100289A1 (no) |
HR (1) | HRP20010141A2 (no) |
HU (1) | HUP0103369A3 (no) |
IL (1) | IL141241A0 (no) |
NO (1) | NO20010982L (no) |
PE (1) | PE20001031A1 (no) |
PL (1) | PL346317A1 (no) |
TR (1) | TR200100600T2 (no) |
WO (1) | WO2000012116A1 (no) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
WO2001051071A2 (en) * | 2000-01-11 | 2001-07-19 | Novo Nordisk A/S | Transepithelial delivery of glp-1 derivatives |
US6540983B1 (en) * | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
AU2001264789A1 (en) * | 2000-06-08 | 2001-12-17 | Eli Lilly And Company | Protein powder for pulmonary delivery |
NZ523693A (en) * | 2000-07-10 | 2004-08-27 | Chiron Corp | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
EP1542712A2 (en) * | 2001-06-01 | 2005-06-22 | Eli Lilly And Company | Glp-1 formulations with protracted time action |
KR20040054729A (ko) | 2001-10-18 | 2004-06-25 | 브리스톨-마이어스 스큅 컴퍼니 | 인간 글루카곤-유사-펩티드-1 모방체, 및 당뇨병 및 이와관련된 증상의 치료에 있어서 이의 용도 |
US7238671B2 (en) | 2001-10-18 | 2007-07-03 | Bristol-Myers Squibb Company | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
EP1894591B1 (en) | 2002-03-20 | 2013-06-26 | MannKind Corporation | Cartridge for an inhalation apparatus |
JP4828940B2 (ja) * | 2002-08-01 | 2011-11-30 | マンカインド コーポレイション | 細胞輸送組成物およびこれらの使用 |
US8921311B2 (en) | 2003-08-01 | 2014-12-30 | Mannkind Corporation | Method for treating hyperglycemia |
DE602004026113D1 (de) | 2003-12-18 | 2010-04-29 | Novo Nordisk As | Glp-1-verbindungen |
US7709639B2 (en) | 2004-08-20 | 2010-05-04 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
EP1791542B1 (en) | 2004-08-23 | 2015-05-20 | Mannkind Corporation | Diketopiperazine salts for drug delivery |
KR100704447B1 (ko) * | 2005-05-16 | 2007-04-09 | 정용현 | 3단계로 코팅되는 김치 유산균의 코팅방법 및 그로부터 제조된 코팅된 김치유산균 및 코팅된 김치 유산균이 함유된 조성물 |
ES2559677T3 (es) | 2005-09-14 | 2016-02-15 | Mannkind Corporation | Método de formulación de fármacos basado en aumentar la afinidad de los principios activos por superficies de partículas microcristalinas |
SI1965823T1 (sl) * | 2005-11-04 | 2016-09-30 | Glaxosmithkline Llc Corporation Service Company | Postopki za dajanje hipoglikemičnih sredstev |
US8293869B2 (en) | 2005-12-16 | 2012-10-23 | Nektar Therapeutics | Polymer conjugates of GLP-1 |
KR20080096809A (ko) | 2006-02-22 | 2008-11-03 | 맨카인드 코포레이션 | 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법 |
JO2945B1 (en) * | 2006-09-13 | 2016-03-15 | سميث كلاين بيتشام كوربوريشن | Methods of giving prolonged hypoglycemic agents |
EP2502618A3 (en) | 2007-04-30 | 2012-10-03 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
JP2009019027A (ja) | 2007-07-16 | 2009-01-29 | Hanmi Pharmaceutical Co Ltd | アミノ末端のアミノ酸が変異したインスリン分泌ペプチド誘導体 |
AU2008316634B2 (en) * | 2007-10-24 | 2014-02-27 | Mannkind Corporation | Method of preventing adverse effects by GLP-1 |
CA3086027C (en) | 2008-06-13 | 2022-05-17 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
DK2300083T3 (da) | 2008-06-20 | 2013-07-22 | Mannkind Corp | Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
CA2749099A1 (en) | 2009-01-08 | 2010-07-15 | Mannkind Corporation | Method for treating hyperglycemia with glp-1 |
EP2405963B1 (en) | 2009-03-11 | 2013-11-06 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
BRPI1013154B1 (pt) | 2009-06-12 | 2020-04-07 | Mannkind Corp | Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
KR20140095483A (ko) | 2011-10-24 | 2014-08-01 | 맨카인드 코포레이션 | 통증을 치료하기 위한 방법 및 조성물 |
RU2650035C2 (ru) | 2012-07-12 | 2018-04-06 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
CN105102436B (zh) | 2013-03-15 | 2018-06-12 | 曼金德公司 | 微晶二酮哌嗪组合物以及方法 |
KR102321339B1 (ko) | 2013-07-18 | 2021-11-02 | 맨카인드 코포레이션 | 열-안정성 건조 분말 약제학적 조성물 및 방법 |
CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2018155254A1 (ja) | 2017-02-21 | 2018-08-30 | Jfeスチール株式会社 | 高炭素熱延鋼板およびその製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545618A (en) * | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
DK36492D0 (da) * | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Praeparat |
NZ250844A (en) * | 1993-04-07 | 1996-03-26 | Pfizer | Treatment of non-insulin dependant diabetes with peptides; composition |
US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
DE122009000079I2 (de) * | 1996-08-30 | 2011-06-16 | Novo Nordisk As Novo Alle | Glp-1 derivate |
UA65549C2 (uk) * | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
EP1019031A4 (en) * | 1997-07-18 | 2003-02-05 | Infimed Inc | BIODEGRADABLE MACROMERS FOR THE REGULATED RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES |
-
1999
- 1999-08-24 EA EA200100289A patent/EA200100289A1/ru unknown
- 1999-08-24 PL PL99346317A patent/PL346317A1/xx not_active Application Discontinuation
- 1999-08-24 AU AU55841/99A patent/AU764371B2/en not_active Ceased
- 1999-08-24 JP JP2000567230A patent/JP2002523466A/ja not_active Withdrawn
- 1999-08-24 IL IL14124199A patent/IL141241A0/xx unknown
- 1999-08-24 TR TR2001/00600T patent/TR200100600T2/xx unknown
- 1999-08-24 CN CN99810174A patent/CN1314818A/zh active Pending
- 1999-08-24 HU HU0103369A patent/HUP0103369A3/hu unknown
- 1999-08-24 AR ARP990104231A patent/AR022368A1/es unknown
- 1999-08-24 CA CA002341454A patent/CA2341454A1/en not_active Abandoned
- 1999-08-24 KR KR1020017002518A patent/KR20010073033A/ko not_active Application Discontinuation
- 1999-08-24 CZ CZ2001690A patent/CZ2001690A3/cs unknown
- 1999-08-24 BR BR9913284-2A patent/BR9913284A/pt not_active IP Right Cessation
- 1999-08-24 WO PCT/US1999/019348 patent/WO2000012116A1/en not_active Application Discontinuation
- 1999-08-24 CO CO99053457A patent/CO5090908A1/es unknown
- 1999-08-25 EP EP99306733A patent/EP0997151B1/en not_active Revoked
- 1999-08-25 PE PE1999000857A patent/PE20001031A1/es not_active Application Discontinuation
- 1999-08-25 DE DE69934380T patent/DE69934380D1/de not_active Expired - Lifetime
- 1999-08-25 AT AT99306733T patent/ATE347902T1/de not_active IP Right Cessation
-
2001
- 2001-02-27 HR HR20010141A patent/HRP20010141A2/hr not_active Application Discontinuation
- 2001-02-27 NO NO20010982A patent/NO20010982L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5584199A (en) | 2000-03-21 |
JP2002523466A (ja) | 2002-07-30 |
HUP0103369A2 (hu) | 2002-02-28 |
CZ2001690A3 (cs) | 2002-04-17 |
CO5090908A1 (es) | 2001-10-30 |
ATE347902T1 (de) | 2007-01-15 |
AR022368A1 (es) | 2002-09-04 |
CA2341454A1 (en) | 2000-03-09 |
CN1314818A (zh) | 2001-09-26 |
IL141241A0 (en) | 2002-03-10 |
BR9913284A (pt) | 2001-05-15 |
PE20001031A1 (es) | 2000-10-12 |
TR200100600T2 (tr) | 2001-07-23 |
NO20010982L (no) | 2001-04-27 |
DE69934380D1 (de) | 2007-01-25 |
WO2000012116A1 (en) | 2000-03-09 |
PL346317A1 (en) | 2002-01-28 |
EP0997151B1 (en) | 2006-12-13 |
AU764371B2 (en) | 2003-08-14 |
HUP0103369A3 (en) | 2002-03-28 |
EA200100289A1 (ru) | 2001-10-22 |
EP0997151A3 (en) | 2000-09-20 |
KR20010073033A (ko) | 2001-07-31 |
EP0997151A2 (en) | 2000-05-03 |
HRP20010141A2 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010982D0 (no) | FremgangsmÕte for Õ administrere insulinotropiske peptider | |
NO20003050D0 (no) | Metode for Õ administrere monomere insulinanaloger | |
FI970388A (fi) | Menetelmä kuvasekvenssien kontrastin parantamiseksi | |
NO982097D0 (no) | Peptider | |
NO982098D0 (no) | Peptider | |
NO20004773D0 (no) | Forlenget-frigjøringsblandinger | |
DE69938817D1 (de) | Erstellungsverfahren | |
ID27841A (id) | Turunan-turunan biaril terapeutik | |
DE69919784D1 (de) | Spritze | |
FI19991887A (fi) | Menetelmä kalkopyriitin uuttamiseksi | |
DE69901014T2 (de) | Keilantriebsvorrichtung | |
DE69941066D1 (de) | Beatmungsgeräte | |
NO20005179D0 (no) | Medikament behandling | |
ID27483A (id) | Metoda terapi gen | |
ID20685A (id) | Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi | |
DE60037935D1 (de) | Kontinuierliches behandlungssystem | |
DE50004258D1 (de) | Transportvorrichtung | |
FR2791348B1 (fr) | POLYPEPTIDE Npt2B | |
NO20005148L (no) | FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider | |
NO20012133D0 (no) | Smertestillende kur | |
FI981338A0 (fi) | Menetelmä multikomponentti-alfa-interferonin valmistamiseksi | |
NO20012283D0 (no) | Koblede peptider | |
FR2780440B1 (fr) | Plate-forme marchepieds | |
DE69936533D1 (de) | Neue behandlungsmethode | |
DE29807617U1 (de) | Spritze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |